Please login to the form below

Not currently logged in
Email:
Password:

cancer

This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.

Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer

Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer

In February, Janssen revealed additional results for Erleada, this time in combination with androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). ... In the EU, Erleada is approved for the treatment of

Latest news

More from news
Approximately 715 fully matching, plus 3,150 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 8 fully matching, plus 339 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 209 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 43 fully matching, plus 207 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics